How can pharma manage rising trial costs?
Clinical trial costs have been rising year-on-year, with companies working to balance the scales and keep studies running despite declining…
Analysis
Can AI replace medical writers? Experts say not immediately
WHO releases Lancet papers that delve further into clinical trial guidance
Sigrid’s Carb Fence tech targets patients being left behind by GLP1s
Duchenne muscular dystrophy: Five trials to watch
Rising Sirturo resistance highlights urgent need for new TB therapies
Funding drought: how can biotech and biopharma keep trials running?
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply
